Abstract:BackgroundIncreasing evidence has suggested that inflammation is related to tumorigenesis and tumor progression. However, the roles of immune-related genes in the occurrence, development, and prognosis of glioblastoma multiforme (GBM) remain to be studied.MethodsThe GBM-related RNA sequencing (RNA-seq), survival, and clinical data were acquired from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Chinese Glioma Genome Atlas (CGGA), and Gene Expression Omnibus (GEO) databases. Immune-related genes were obtained from the Molecular Signatures Database (MSigDB). Differently expressed immune-related genes (DE-IRGs) between GBM and normal samples were identified. Prognostic genes associated with GBM were selected by Kaplan–Meier survival analysis, Least Absolute Shrinkage and Selection Operator (LASSO)-penalized Cox regression analysis, and multivariate Cox analysis. An immune-related gene signature was developed and validated in TCGA and CGGA databases separately. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to explore biological functions of the signature. The correlation between immune cell infiltration and the signature was analyzed by single-sample gene set enrichment analysis (ssGSEA), and the diagnostic value was investigated. The gene set enrichment analysis (GSEA) was performed to explore the potential function of the signature genes in GBM, and the protein–protein interaction (PPI) network was constructed.ResultsThree DE-IRGs [Pentraxin 3 (PTX3), TNFSF9, and bone morphogenetic protein 2 (BMP2)] were used to construct an immune-related gene signature. Receiver operating characteristic (ROC) curves and Cox analyses confirmed that the 3-gene-based prognostic signature was a good independent prognostic factor for GBM patients. We found that the signature was mainly involved in immune-related biological processes and pathways, and multiple immune cells were disordered between the high- and low-risk groups. GSEA suggested that PTX3 and TNFSF9 were mainly correlated with interleukin (IL)-17 signaling pathway, nuclear factor kappa B (NF-κB) signaling pathway, tumor necrosis factor (TNF) signaling pathway, and Toll-like receptor signaling pathway, and the PPI network indicated that they could interact directly or indirectly with inflammatory pathway proteins. Quantitative real-time PCR (qRT-PCR) indicated that the three genes were significantly different between target tissues.ConclusionThe signature with three immune-related genes might be an independent prognostic factor for GBM patients and could be associated with the immune cell infiltration of GBM patients.

Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma

The Potential of DEirlncRNAs: A Novel Approach to Predict Glioblastoma Prognosis

Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma

Construction of an Immune-Related Gene Signature for the Prognosis and Diagnosis of Glioblastoma Multiforme.

Development of a Novel Angiogenesis-Related Lncrna Signature to Predict the Prognosis and Immunotherapy of Glioblastoma Multiforme.

Identification of angiogenesis‐related genes signature for predicting survival and its regulatory network in glioblastoma

Prognostic Model and Nomogram Construction and Validation with an Autophagy-Related Gene Signature in Low-Grade Gliomas

Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses

A Novel 16-Genes Signature Scoring System As Prognostic Model to Evaluate Survival Risk in Patients with Glioblastoma

Development of Prognostic Indicator Based on AU-Rich Elements-Related Genes in Glioblastoma

A Promising Glycolysis- and Immune-Related Prognostic Signature for Glioblastoma

Bioinformatics Evaluation of a Novel Angiogenesis Related Genes-Based Signature for Predicting Prognosis and Therapeutic Efficacy in Patients with Gastric Cancer.

A novel ARHGAP family gene signature for survival prediction in glioma patients

Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics

Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma

Identification of a Potential Prognostic Signature based on Immune-related Genes in Primary Glioblastoma

An immune-related gene pair signature predicts the prognosis and immunotherapeutic response in glioblastoma

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma

An Autophagic Gene‐based Signature to Predict the Survival of Patients with Low‐grade Gliomas

Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.

Establishment and validation of five autophagy-related signatures for predicting survival and immune microenvironment in glioma